FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3212350173> ?p ?o ?g. }

• W3212350173 endingPage "709" @default.
• W3212350173 startingPage "698" @default.
• W3212350173 abstract "Cerebral small vessel disease is characterized by progressive cerebral white matter changes (WMCs). This study aimed to compare the effects of cilostazol and aspirin on changes in WMC volume in patients with cerebral small vessel disease.In a multicenter, double-blind, randomized controlled trial, participants with moderate or severe WMCs and at least one lacunar infarction detected on brain magnetic resonance imaging were randomly assigned to the cilostazol and aspirin groups in a 1:1 ratio. Cilostazol slow release (200 mg) or aspirin (100 mg) capsules were administered once daily for 2 years. The primary outcome was the change in WMC volume on magnetic resonance images from baseline to 2 years. Secondary imaging outcomes include changes in the number of lacunes or cerebral microbleeds, fractional anisotropy, and mean diffusivity on diffusion tensor images, and brain atrophy. Secondary clinical outcomes include all ischemic strokes, all ischemic vascular events, and changes in cognition, motor function, mood, urinary symptoms, and disability.Between July 2013 and August 2016, 256 participants were randomly assigned to the cilostazol (n=127) and aspirin (n=129) groups. Over 2 years, the percentage of WMC volume to total WM volume and the percentage of WMC volume to intracranial volume increased in both groups, but neither analysis showed significant differences between the groups. The peak height of the mean diffusivity histogram in normal-appearing WMs was significantly reduced in the aspirin group compared with the cilostazol group. Cilostazol significantly reduced the risk of ischemic vascular event compared with aspirin (0.5 versus 4.5 cases per 100 person-years; hazard ratio, 0.11 [95% CI, 0.02-0.89]).There was no significant difference between the effects of cilostazol and aspirin on WMC progression in patients with cerebral small vessel disease. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01932203." @default.
• W3212350173 created "2021-11-22" @default.
• W3212350173 creator A5003202205 @default.
• W3212350173 creator A5012106415 @default.
• W3212350173 creator A5013293945 @default.
• W3212350173 creator A5015283188 @default.
• W3212350173 creator A5019254683 @default.
• W3212350173 creator A5019819118 @default.
• W3212350173 creator A5022150256 @default.
• W3212350173 creator A5022350068 @default.
• W3212350173 creator A5023800103 @default.
• W3212350173 creator A5033030009 @default.
• W3212350173 creator A5039880005 @default.
• W3212350173 creator A5051680529 @default.
• W3212350173 creator A5060234455 @default.
• W3212350173 creator A5062304322 @default.
• W3212350173 creator A5064239107 @default.
• W3212350173 creator A5067358658 @default.
• W3212350173 creator A5069341668 @default.
• W3212350173 creator A5072249558 @default.
• W3212350173 creator A5073477378 @default.
• W3212350173 creator A5073636848 @default.
• W3212350173 creator A5075083918 @default.
• W3212350173 creator A5083299968 @default.
• W3212350173 creator A5083363274 @default.
• W3212350173 date "2022-03-01" @default.
• W3212350173 modified "2023-10-15" @default.
• W3212350173 title "Cilostazol Versus Aspirin on White Matter Changes in Cerebral Small Vessel Disease: A Randomized Controlled Trial" @default.
• W3212350173 cites W1482496268 @default.
• W3212350173 cites W1974704788 @default.
• W3212350173 cites W1984133805 @default.
• W3212350173 cites W2011082917 @default.
• W3212350173 cites W2016116109 @default.
• W3212350173 cites W2028736253 @default.
• W3212350173 cites W2032575292 @default.
• W3212350173 cites W2032752142 @default.
• W3212350173 cites W2033809837 @default.
• W3212350173 cites W2034943295 @default.
• W3212350173 cites W2051880645 @default.
• W3212350173 cites W2071881327 @default.
• W3212350173 cites W2083726603 @default.
• W3212350173 cites W2099884864 @default.
• W3212350173 cites W2104901197 @default.
• W3212350173 cites W2107388590 @default.
• W3212350173 cites W2108696783 @default.
• W3212350173 cites W2113524373 @default.
• W3212350173 cites W2125630263 @default.
• W3212350173 cites W2131339155 @default.
• W3212350173 cites W2136573752 @default.
• W3212350173 cites W2138595885 @default.
• W3212350173 cites W2141796362 @default.
• W3212350173 cites W2144212512 @default.
• W3212350173 cites W2148023482 @default.
• W3212350173 cites W2153480371 @default.
• W3212350173 cites W2155894782 @default.
• W3212350173 cites W2156717321 @default.
• W3212350173 cites W2157848968 @default.
• W3212350173 cites W2158742097 @default.
• W3212350173 cites W2590427419 @default.
• W3212350173 cites W2617433984 @default.
• W3212350173 cites W2617459366 @default.
• W3212350173 cites W2736307756 @default.
• W3212350173 cites W2799775313 @default.
• W3212350173 cites W2804221421 @default.
• W3212350173 cites W2905456986 @default.
• W3212350173 cites W2937097483 @default.
• W3212350173 cites W2939837823 @default.
• W3212350173 cites W2945075257 @default.
• W3212350173 cites W2946066695 @default.
• W3212350173 cites W2950086191 @default.
• W3212350173 cites W2996130557 @default.
• W3212350173 cites W4235770099 @default.
• W3212350173 doi "https://doi.org/10.1161/strokeaha.121.035766" @default.
• W3212350173 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34781708" @default.
• W3212350173 hasPublicationYear "2022" @default.
• W3212350173 type Work @default.
• W3212350173 sameAs 3212350173 @default.
• W3212350173 citedByCount "4" @default.
• W3212350173 countsByYear W32123501732022 @default.
• W3212350173 countsByYear W32123501732023 @default.
• W3212350173 crossrefType "journal-article" @default.
• W3212350173 hasAuthorship W3212350173A5003202205 @default.
• W3212350173 hasAuthorship W3212350173A5012106415 @default.
• W3212350173 hasAuthorship W3212350173A5013293945 @default.
• W3212350173 hasAuthorship W3212350173A5015283188 @default.
• W3212350173 hasAuthorship W3212350173A5019254683 @default.
• W3212350173 hasAuthorship W3212350173A5019819118 @default.
• W3212350173 hasAuthorship W3212350173A5022150256 @default.
• W3212350173 hasAuthorship W3212350173A5022350068 @default.
• W3212350173 hasAuthorship W3212350173A5023800103 @default.
• W3212350173 hasAuthorship W3212350173A5033030009 @default.
• W3212350173 hasAuthorship W3212350173A5039880005 @default.
• W3212350173 hasAuthorship W3212350173A5051680529 @default.
• W3212350173 hasAuthorship W3212350173A5060234455 @default.
• W3212350173 hasAuthorship W3212350173A5062304322 @default.
• W3212350173 hasAuthorship W3212350173A5064239107 @default.
• W3212350173 hasAuthorship W3212350173A5067358658 @default.
• W3212350173 hasAuthorship W3212350173A5069341668 @default.

• next